Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Christ

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Pharmacology|January 1, 1996
Nonpeptide angiotensin II receptor antagonist: pharmacokinetics and pharmacodynamics in rats of EXP3174, an active metabolite of losartanP C Wong, D D Christ, Y N Wong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1994
Induction of cytochromes P-450 2B and 3A in mice following the dietary administration of the novel cognitive enhancer linopirdineS Diamond, D Rakestraw, J O'Neil, et al.
Anesthesiology|December 1, 1988
Enflurane metabolism produces covalently bound liver adducts recognized by antibodies from patients with halothane hepatitisD D Christ, J G Kenna, W Kammerer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 26, 1999
Liquid chromatography/mass spectrometry and high-field nuclear magnetic resonance characterization of novel mixed diconjugates of the non-nucleoside human immunodeficiency virus-1 reverse transcriptase inhibitor, efavirenzA E Mutlib, H Chen, G Nemeth, et al.
Journal of Cardiovascular Pharmacology|December 5, 1997
Pharmacokinetic-pharmacodynamic relations of losartan and EXP3174 in a porcine animal modelS M Lankford, D Plummer, P Hellyer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1994
Analysis of the thrombin inhibitor DuP 714 by an enzyme-linked immunosorbent assayT J Mitchell, R M Knabb, D D Christ, et al.
European Journal of Pharmacology|June 5, 1992
Monoclonal antibodies to the nonpeptide angiotensin II receptor antagonist, losartanT M Reilly, D D Christ, J V Duncia, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 24, 2001
Mass spectrometric and NMR characterization of metabolites of roxifiban, a potent and selective antagonist of the platelet glycoprotein IIb/IIIa receptorA E Mutlib, S Diamond, J Shockcor, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
Synthesis and biological activities of potential metabolites of the non-nucleoside reverse transcriptase inhibitor efavirenzJ A Markwalder, D D Christ, A Mutlib, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1989
Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesteraseH Satoh, B M Martin, A H Schulick, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Pharmacology|January 1, 1996
Nonpeptide angiotensin II receptor antagonist: pharmacokinetics and pharmacodynamics in rats of EXP3174, an active metabolite of losartanP C Wong, D D Christ, Y N Wong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1994
Induction of cytochromes P-450 2B and 3A in mice following the dietary administration of the novel cognitive enhancer linopirdineS Diamond, D Rakestraw, J O'Neil, et al.
Anesthesiology|December 1, 1988
Enflurane metabolism produces covalently bound liver adducts recognized by antibodies from patients with halothane hepatitisD D Christ, J G Kenna, W Kammerer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 26, 1999
Liquid chromatography/mass spectrometry and high-field nuclear magnetic resonance characterization of novel mixed diconjugates of the non-nucleoside human immunodeficiency virus-1 reverse transcriptase inhibitor, efavirenzA E Mutlib, H Chen, G Nemeth, et al.
Journal of Cardiovascular Pharmacology|December 5, 1997
Pharmacokinetic-pharmacodynamic relations of losartan and EXP3174 in a porcine animal modelS M Lankford, D Plummer, P Hellyer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1994
Analysis of the thrombin inhibitor DuP 714 by an enzyme-linked immunosorbent assayT J Mitchell, R M Knabb, D D Christ, et al.
European Journal of Pharmacology|June 5, 1992
Monoclonal antibodies to the nonpeptide angiotensin II receptor antagonist, losartanT M Reilly, D D Christ, J V Duncia, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 24, 2001
Mass spectrometric and NMR characterization of metabolites of roxifiban, a potent and selective antagonist of the platelet glycoprotein IIb/IIIa receptorA E Mutlib, S Diamond, J Shockcor, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
Synthesis and biological activities of potential metabolites of the non-nucleoside reverse transcriptase inhibitor efavirenzJ A Markwalder, D D Christ, A Mutlib, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1989
Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesteraseH Satoh, B M Martin, A H Schulick, et al.
Pageof 3